Comparative evaluation of three clinical decision support systems: Prospective screening for medication errors in 100 medical inpatients

European Journal of Clinical Pharmacology

Volumn 68, Issue 8, 2012, Pages 1209-1219

  Fritz, Daniela ^a   Ceschi, Alessandro ^a,b   Curkovic, Ivanka ^a   Huber, Martin ^a   Egbring, Marco ^a   Kullak Ublick, Gerd A ^a,c   Russmann, Stefan ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Schweizerisches Toxikologisches Informationszentrum   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Clinical decision support software; Dose adjustment; Drug interactions

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTITHROMBOCYTIC AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDESONIDE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM SALT; CIPROFLOXACIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRONE; DIURETIC AGENT; HEPARIN DERIVATIVE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN DERIVATIVE; ITRACONAZOLE; LAXATIVE; PANTOPRAZOLE; PARACETAMOL; POTASSIUM SALT; PREDNISONE; PROTON PUMP INHIBITOR; TORASEMIDE; UNINDEXED DRUG; VITAMIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLECYSTITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DRUG ABSORPTION; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL PATIENT; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; NATURALISTIC INQUIRY; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SHUNT THROMBOSIS;

AGED; AGED, 80 AND OVER; CLINICAL PHARMACY INFORMATION SYSTEMS; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG TOXICITY; FEMALE; HUMANS; INPATIENTS; MALE; MEDICATION ERRORS; MIDDLE AGED; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES;

EID: 84866504271     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1241-6     Document Type: Article

References (38)

1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R et al (1995) Incidence of adverse drug events and potential adverse drug events. implications for prevention. ADE Prevention Study Group. JAMA 274(1):29-34.
2. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301-306.
3. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 56(2):181-186.
4. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200-1205.
5. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329(7456):15-19.
6. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA (2003) Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289(13):1652-1658.
7. Juurlink DN, MamdaniMM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351 (6):543-551.
8. Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U (2008) The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc 15(5):585-600.
9. Feldstein AC, Smith DH, Perrin N, Yang X, Rix M, Raebel MA, Magid DJ, Simon SR, Soumerai SB (2006) Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med 166(17):1848-1854.
10. Kaushal R, Kern LM, Barron Y, Quaresimo J, Abramson EL (2010) Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med 25(6):530- 536.
11. Kaushal R, Shojania KG, Bates DW (2003) Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 163(12):1409-1416.
12. Smith DH, Perrin N, Feldstein A, Yang X, Kuang D, Simon SR, Sittig DF, Platt R, Soumerai SB (2006) The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med 166(10):1098-1104.
13. Eslami S, de Keizer NF, Abu-Hanna A (2008) The impact of computerized physician medication order entry in hospitalized patients-a systematic review. Int J Med Inform 77(6):365-376.
14. van Doormaal JE, van den Bemt PM, Zaal RJ, Egberts AC, Lenderink BW, Kosterink JG, Haaijer-Ruskamp FM, Mol PG (2009) The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted timeseries study. J Am Med Inform Assoc 16(6):816-825.
15. Wolfstadt JI, Gurwitz JH, Field TS, Lee M, Kalkar S, Wu W, Rochon PA (2008) The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 23(4):451-458.
16. Olvey EL, Clauschee S, Malone DC (2010) Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clin Pharmacol Ther 87(1):48-51.
17. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB (2004) Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc 44(2):136-141.
18. Vonbach P, Dubied A, Krahenbuhl S, Beer JH (2008) Evaluation of frequently used drug interaction screening programs. Pharm World Sci 30(4):367-374.
19. van Doormaal JE, Mol PG, van den Bemt PM, Zaal RJ, Egberts AC, Kosterink JG, Haaijer-Ruskamp FM (2008) Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiol Drug Saf 17(7):645-654.
20. Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL (2010) Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings. Ann Pharmacother 44 (11):1718-1724.
21. Vonbach P, Dubied A, Beer JH, Krahenbuhl S (2007) Recognition and management of potential drug-drug interactions in patients on internal medicine wards. Eur J Clin Pharmacol 63(11):1075-1083.
22. van der Sijs H, Mulder A, van Gelder T, Aarts J, Berg M, Vulto A (2009) Drug safety alert generation and overriding in a large Dutch University Medical Centre. Pharmacoepidemiol Drug Saf 18 (10):941-947.
23. Thomson Reuters DRUG-REAX SYSTEM. Available at: http://thomsonreuters. com/products-services/healthcare/healthcare-products/a-z/drug-reax-system.
24. Pharmavista Interactions (2011). Available at: http://www.pharmavista.ch.
25. ID Berlin ID PHARMA CHECK. Available at: http://www.id-berlin.de.
26. Albengres E, Le Louet H, Tillement JP (1998) Systemic antifungal agents. drug interactions of clinical significance. Drug Saf 18(2):83-97.
27. Hempfling W, Grunhage F, Dilger K, Reichel C, BeuersU, Sauerbruch T (2003) Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 38 (1):196-202.
28. Haueis P, Greil W, Huber M, Grohmann R, Kullak-Ublick GA, Russmann S (2011) Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software. Clin Pharmacol Ther 90 (4):588-596.
29. Taylor LK, Tamblyn R (2004) Reasons for physician nonadherence to electronic drug alerts. Stud Health Technol Inform 107(Pt 2):1101-1105.
30. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS (2003) Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 163(21):2625-2631.
31. Shah NR, Seger AC, Seger DL, Fiskio JM, Kuperman GJ, Blumenfeld B, Recklet EG, Bates DW, Gandhi TK (2006) Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 13(1):5-11.
32. Tamblyn R, Huang A, Taylor L, Kawasumi Y, Bartlett G, Grad R, Jacques A, Dawes M, Abrahamowicz M, Perreault R, Winslade N, Poissant L, Pinsonneault A (2008) A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care. J Am Med Inform Assoc 15(4):430- 438.
33. Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN (2009) Overrides of medication alerts in ambulatory care. Arch Intern Med 169(3):305-311.
34. Weingart SN, Simchowitz B, Shiman L, Brouillard D, Cyrulik A, Davis RB, Isaac T, Massagli M, Morway L, Sands DZ, Spencer J, Weissman JS (2009) Clinicians' assessments of electronic medication safety alerts in ambulatory care. Arch InternMed 169(17):1627- 1632.
35. Hansten PD, Horn JR, Hazlet TK (2001) ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc (Wash) 41 (2):161-165.
36. Frölich T, Zorina O, Fontana AO, Kullak-Ublick GA, Vollenweider A, Russmann S (2011) Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification. Eur J Clin Pharmacol 67:1273-1282.
37. Guzek M, Zorina OI, Semmler A, Gonzenbach RR, Huber M, Kullak-Ublick GA, Weller M, Russmann S (2011) Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System). Pharmacoepidemiol Drug Saf 20(9):930-938.
38. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352 (10):969-977.